Youth Social Media Warning; Powassan Virus Death; Cancer Warnings on Alcohol Labels

Note that some links may require subscriptions.

The U.S. Surgeon General called for immediate action by technology companies, policymakers, and families to protect youth mental health on social media.

The FDA approved nalmefene (Opvee) nasal spray to reverse opioid overdoses, a drug similar to naloxone with longer effects.

The agency also approved an autoinjector option for dalimumab-adbm (Cyltezo), an interchangeable biosimilar to adalimumab (Humira), to treat multiple chronic inflammatory diseases, Boehringer Ingelheim announced.

Women with adverse outcomes during pregnancy had a higher risk of midlife stroke. (Stroke)

Treatment with oral semaglutide (Wegovy) led to 15.1% reduction in weight after 68 weeks compared with a 2.4% reduction with placebo, Novo Nordisk said.

A Portland man died from Powassan virus disease, the first reported death in Maine from the untreatable tick-borne illness in 2023. (CBS News)

Brazil declared a state of animal health emergency in response to its first ever detection of the highly pathogenic avian influenza virus in wild birds. (Reuters)

Ireland will require calorie counts and cancer warnings on alcoholic beverage labels. (NPR)

The Federal Trade Commission is employing an aggressive approach against drug companies and industry middlemen. (KFF Health News)

A senior advisor said the WHO’s response to health emergencies is “overstretched” from the demands of multiple disease outbreaks and natural disasters. (Reuters)

What’s next for COVID-19 vaccines? (CNBC)

Singapore’s Prime Minster Lee Hsien Loong, 71, announced that he tested positive for COVID-19 for the first time. (ABC News)

Tennis champion Martina Navratilova said she’s doing “OK” after being diagnosed with throat cancer and breast cancer. (AP)

Screening adults for chronic kidney disease every 10 years from ages 35 to 75 may reduce the need for dialysis or transplants. (Annals of Internal Medicine)

The FDA approved avapritinib (Ayvakit) as for indolent systemic mastocytosis, a rare hematologic disorder that can have a significant impact on patients’ quality of life.